Eric E Poma insider trades

Open-market stock purchases and sales by Eric E Poma, Chief Executive Officer at Calidi Biotherapeutics, Inc, from SEC Form 4 filings since Oct 9, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -92%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • CLDI Calidi Biotherapeutics, Inc: 1 buy, last Sep 3, 2025
  • MTEM Molecular Templates, Inc: other filings, last Jan 23, 2024

Get free alerts when Eric E Poma files a new trade →